Study of STA-9090, Administered Once-Weekly in Patients With Solid Tumors
Clinical trial NCT00687934 · COMPLETED
Trial details
- NCT number
- NCT00687934
- Sponsor
- Synta Pharmaceuticals Corp.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-10-01
- Primary completion
- 2011-06-01
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.